Inventor · disambiguated record
George L. King
Also filed as: KING GEORGE L · KING GEORGE LIANG
12 granted patents·11 pending applications·152 citations·filing 1997–2020
90Inventor score
Files withJOSLIN DIABETES CENTER INC10JOSLIN DIABETES CT INC A MASSA2KING GEORGE L2LILLY CO ELI2XOMA TECHNOLOGY LTD2
Top patents by PatentIndex Score
23 records- 0192US7175844B2Methods of modulating fibrosisJOSLIN DIABETES CENTER INC·Filed 2001·Granted Feb 13, 2007·65 cites·26 claims
- 0282US6753341B1Inhibition of PKC to treat permability failureJOSLIN DIABETES CENTER INC·Filed 2000·Granted Jun 22, 2004·12 cites·10 claims
- 0381US9921221B2Predicting and treating diabetic complicationsJOSLIN DIABETES CENTER INC·Filed 2013·Granted Mar 20, 2018·6 cites·8 claims
- 0470US6284751B1Therapeutic treatment for VEGF related diseasesLILLY CO ELI·Filed 1999·Granted Sep 4, 2001·30 cites·4 claims
- 0564US6114320ATherapeutic treatment for VEGF related ocular diseasesLILLY CO ELI·Filed 1997·Granted Sep 5, 2000·21 cites·12 claims
- 0660US2005020662A1Inhibition of PKC to treat permability failureJOSLIN DIABETES CT INC A MASSA·Filed 2004·Application pending·0 cites
- 0758US6811993B2Diagnostic and screening methods based on monocyte PKC activityJOSLIN DIABETES CENTER INC·Filed 2001·Granted Nov 2, 2004·2 cites·7 claims
- 0857US7291451B2Modulation of pericyte proliferationXOMA TECHNOLOGY LTD·Filed 2004·Granted Nov 6, 2007·1 cites·2 claims
- 0957US2008038245A1Methods of modulating angiogenesisKING GEORGE L·Filed 2006·Application pending·0 cites
- 1054US6131578AInhibitors of UDP-G1cNAc:Ga1β1-3Ga1NAcαR β1-6 N-acetylglucosaminyltransferase (core 2 G1cNAc-T) and use of the inhibitors to prevent or treat cardiomyopathy associated with diabetesFiled 1997·Granted Oct 17, 2000·15 cites·10 claims
- 1154US2021000855A1Retinol-binding protein 3 (rbp3) as a protective factor in non-diabetic retinal degenerationJOSLIN DIABETES CENTER INC·Filed 2020·Application pending·0 cites
- 1253US8343939B2Methods of modulating angiogenesisJOSLIN DIABETES CENTER INC·Filed 2009·Granted Jan 1, 2013·0 cites·3 claims
- 1353US2002048582A1Methods of modulating angiogenesisFiled 2001·Application pending·0 cites
- 1452US2008119410A1Modulation of Pericyte ProliferationXOMA TECHNOLOGY LTD·Filed 2007·Application pending·0 cites
- 1552US2002165158A1Methods of modulating angiogenesisFiled 2002·Application pending·0 cites
- 1651US2002048581A1Modulation of nitric oxide synthase by PKCFiled 2001·Application pending·0 cites
- 1750US7410756B2Methods of modulating angiogenesisJOSLIN DIABETES CENTER INC·Filed 2003·Granted Aug 12, 2008·0 cites·3 claims
- 1848US2004023386A1Modulation of nitric oxide synthase by PKCJOSLIN DIABETES CT INC A MASSA·Filed 2003·Application pending·0 cites
- 1945US9283262B2Predicting and treating diabetic complicationsKING GEORGE L·Filed 2011·Granted Mar 15, 2016·0 cites·5 claims
- 2041US8372582B2Methods of modulating metabolic memoryJOSLIN DIABETES CENTER INC·Filed 2007·Granted Feb 12, 2013·0 cites·8 claims
- 2139US2002173464A1Modulation of pericyte proliferationFiled 2001·Application pending·0 cites
- 2239US2018140626A1Retinol-binding protein 3 (rbp3) as a protective factor in non-diabetic retinal degenerationJOSLIN DIABETES CENTER INC·Filed 2016·Application pending·0 cites
- 2336US2018066327A1Methods to Accelerate Wound Healing in Diabetic SubjectsJOSLIN DIABETES CENTER INC·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →